Young Li
Stock Analyst at Jefferies
(1.37)
# 3,347
Out of 4,749 analysts
5
Total ratings
66.67%
Success rate
-8.07%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $33.87 | +112.58% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $96.55 | +19.11% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.10 | +13.64% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $46.98 | +27.71% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $17.06 | +169.64% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $33.87
Upside: +112.58%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $96.55
Upside: +19.11%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.10
Upside: +13.64%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $46.98
Upside: +27.71%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $17.06
Upside: +169.64%